Brainsway, which sells medical devices that use magnetic stimulation to treat depression and OCD, raised $28 million by offering 2.5 million ADSs at $11. At $11, Brainsway commands a market cap of $119 million.
The company had previously filed to raise $30 million by offering 2.5 million ADSs at $11.94.
Brainsway plans to list on the Nasdaq under the symbol BWAY. Cantor Fitzgerald, Raymond James and Oppenheimer & Co. acted as lead managers on the deal.
